Dense Breast denials in California external review

In the California DMHC record, independent physician reviewers decided 19 published external-review cases involving dense breastand overturned the plan’s denial in 94.7%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
19
2014–2017
Overturned
94.7%
18 denials reversed

Most-fought treatments for dense breast

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Digital Breast Tomosynthesis9
100%
Breast Tomosynthesis7
100%
Typical time to a decision
19 days
Most land between 11 and 21 days

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for digital breast tomosynthesis for an annual breast screening examination. Findings: The 3 physician reviewers found that breast tomosynthesis is a technique that was developed several years ago as a problem solving adjunct to routine mammography. Applying the same basic concept as computed tomography scanning, the logic is that by separating the various layers of breast tissue, one can better detect abnormalities. This has been shown to be most useful in the evaluation of dense breasts. It was stated that this patient has dense breasts as well as scattered benign nodules. It is specifically those patients who have dense breasts that can benefit most from digital tomosynthesis. The ability to separate out the overlapping structures enables the possibility of demonstrating an otherwise occult tumor.
Experimental/Investigational · 2016 · IMR EI16-23647
Nature of Statutory Criteria/Case Summary: An enrollee has requested reimbursement for the digital breast tomosynthesis for evaluation of the enrollee’s breast cancer screening. Findings: 2/3 of the physician reviewers found that Tomosynthesis is a technique that was developed as a problem solving adjunct to routine mammography. In this case, the patient has heterogeneously dense breasts. While one could make the argument that her mammogram has not changed since the last study, it is specifically those patients who have dense breasts that can benefit most from tomosynthesis. The ability to separate out the overlapping structures enables the possibility of demonstrating an otherwise occult tumor. Given the support cited above, the breast tomosynthesis was likely to be more beneficial for evaluation of the patient’s medical condition than any available standard therapy.
Experimental/Investigational · 2016 · IMR EI16-24052

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
A 64-year-old female enrollee requested bilateral breast magnetic resonance imaging (MRI) for medical evaluation of the enrollee’s dense breasts. Findings: The physician reviewer found that the submitted documentation fails to demonstrate the medical necessity of the requested diagnostic procedure. This patient has a family history of breast cancer with at least one first-degree relative with the disease. Her breast tissue is heterogeneously dense on mammography. However, the current medical evidence does not support the requested diagnostic procedure in this clinical setting. While MRI is the most sensitive means with which to detect early breast cancer, this technique is medically necessary when there is a greater than 20% lifetime risk of breast cancer or when there is BRCA genetic mutation.
Medical Necessity · 2014 · IMR MN14-18615

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving dense breast, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for dense breast? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9